EUCTR2009-017148-15-IT进行中（未招募）不适用
A retrospective pharmacogenetic analysis of patients with elevated liver enzymes (Hy s law cases or AST/ALT > 10x ULN) in clinical studies CCOX189A0117, CCOX189A2332, CCOX189A2369, CCOX189A0126, CCOX189A0112, CCOX189A0109 or CCOX189A2361 - ND
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Inclusion criteria Patients eligible for inclusion in this study have to fulfill all of the following criteria: 1. Patients who received lumiracoxib and experienced a Hy s law or AST/ALT > 10xULN event after initiating treatment in clinical studies CCOX189A0117, CCOX189A2332, CCOX189A2369, CCOX189A0126, CCOX189A0112, CCOX189A0109 or CCOX189A2361. 2. Written informed consent must be obtained before any assessment is performed. Only patients who agree to participate in this pharmacogenetic post-hoc study by signing the informed consent form will be included in this study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patients who do not provide written informed consent.
研究者
相似试验
招募中
不适用
Pharmacogenetic analysis to investigate the association between efficacy and neurotoxicity of oxaliplatin and single nucleotide polymorphismsColorectal cancerJPRN-UMIN000002490Kyoto University Hospital133
已完成
不适用
Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxifeBreast cancerJPRN-UMIN000001411Saitama Medical University, Saitama International Medical Center100
招募中
不适用
A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patientsgastric cancerJPRN-UMIN000004968Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka100
尚未招募
1 期
The Pharmacogenetic and Pathological Assessment of CYP2C19 Activity in Patients with Advanced CancerAdvanced cancerCancer -ACTRN12605000393651Cancer Trials New Zealand50
进行中（未招募）
不适用
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI